Assembly Biosciences (ASMB) Receivables - Net (2017 - 2026)

Assembly Biosciences' Receivables - Net history runs 10 years deep, the most recent figure standing at $451000.0 for Q1 2026.

• In Q1 2026, Receivables - Net changed N/A year-over-year to $451000.0; the TTM figure through Mar 2026 stood at $451000.0 (changed N/A YoY), while the FY2025 annual figure was $974000.0, changed N/A from the prior year.
• Receivables - Net was $451000.0 for Q1 2026 at Assembly Biosciences, down from $974000.0 in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $1.2 million in Q3 2022 to a low of $43000.0 in Q4 2023.
• Historically, Receivables - Net has averaged $610818.2 across 5 years, with a median of $524000.0 in 2022.
• The sharpest annual moves came in 2022 and 2023: Receivables - Net jumped 180.95% in 2022, then plunged 95.44% in 2023.
• A 5-year view of Receivables - Net shows it stood at $944000.0 in 2022, then slumped by 95.44% to $43000.0 in 2023, then changed by 0.0% to $43000.0 in 2024, then soared by 2165.12% to $974000.0 in 2025, then plunged by 53.7% to $451000.0 in 2026.
• The last three Receivables - Net figures came in at $451000.0 (Q1 2026), $974000.0 (Q4 2025), and $912000.0 (Q3 2025), per Business Quant data.